Indivior Share Price | |
---|---|
Price | 1,385.00 |
Bid | 1,398.00 |
Ask | 1,401.00 |
Change | -21.00 (-1.49%) |
Volume | 329,058 |
Open | 1,406.00 |
High | 1,419.00 |
Low | 1,385.00 |
Prev. Close | 1,406.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.19m |
Market Capitalisation | £1.87b |
Market Size | 500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 828 |
---|---|
Vol. Sold | 255,492 |
Sold Value | £3.55m |
Vol. Bought | 73,237 |
Bought Value | £1.03m |
PE Ratio | 1,763.37427 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
15-May-24 | 16:47:39 | 1,403.6018 | 100 | Unknown* | 1,398.00 | 1,401.00 | 1,404 | O Ordinary Was reported as OTC |
15-May-24 | 16:47:03 | 1,395.894 | 7,000 | Buy* | 1,398.00 | 1,401.00 | 97.71k | O Ordinary |
15-May-24 | 16:35:34 | 1,385.00 | 10 | Sell* | 1,398.00 | 1,401.00 | 138.50 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
15-May-24 | 16:35:34 | 1,385.00 | 285 | Sell* | 1,398.00 | 1,401.00 | 3,947 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
14-May-24 | 09-May-24 | Buy | Mark Stejbach held the position of Independent Non-Executive Director at the time of this trade.Mark Stejbach | 17.98 | USD | 550 | 13,134 |
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.